Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

VNRX

VolitionRX (VNRX)

VolitionRX Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:VNRX
FechaHoraFuenteTítuloSímboloCompañía
13/05/202415:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:VNRXVolitionRX Limited
13/05/202415:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:VNRXVolitionRX Limited
13/05/202415:13Edgar (US Regulatory)Form 8-K - Current reportAMEX:VNRXVolitionRX Limited
13/05/202415:10PR Newswire (US)VolitionRx Limited Announces First Quarter 2024 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
08/05/202407:00PR Newswire (US)VolitionRx Limited Schedules First Quarter 2024 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
23/04/202407:00PR Newswire (US)Nu.Q® Vet Cancer Test launched in-clinic in U.S. and Europe through AntechAMEX:VNRXVolitionRX Limited
26/03/202406:21IH Market NewsU.S. Index Futures on the Rise, Oil Prices Show StabilityAMEX:VNRXVolitionRX Limited
25/03/202415:10PR Newswire (US)VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
21/03/202407:30PR Newswire (US)VolitionRx Limited Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
20/03/202407:30PR Newswire (US)Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in JapanAMEX:VNRXVolitionRX Limited
19/03/202415:30PR Newswire (US)Volition appoints Dr Andrew Retter as Chief Medical OfficerAMEX:VNRXVolitionRX Limited
14/02/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:VNRXVolitionRX Limited
09/02/202414:56Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:VNRXVolitionRX Limited
02/02/202407:00PR Newswire (US)Volition to Share Nu.Q® NETs Strategy Update at Upcoming WebinarAMEX:VNRXVolitionRX Limited
26/01/202415:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:VNRXVolitionRX Limited
04/01/202407:00PR Newswire (US)Volition Issues Business Review 2023AMEX:VNRXVolitionRX Limited
05/12/202307:00PR Newswire (US)VolitionRx Secures Approximately $5.5 Million in Belgium Regional Government Financing from Wallonie EntreprendreAMEX:VNRXVolitionRX Limited
14/11/202315:10PR Newswire (US)VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
08/11/202307:00PR Newswire (US)VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
06/11/202305:24PR Newswire (US)Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & IrelandAMEX:VNRXVolitionRX Limited
23/10/202307:00PR Newswire (US)Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage CancerAMEX:VNRXVolitionRX Limited
19/10/202307:00PR Newswire (US)Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic ShockAMEX:VNRXVolitionRX Limited
18/10/202311:00PR Newswire (US)US Ambassador Adler visits Belgian VolitionAMEX:VNRXVolitionRX Limited
16/10/202307:00PR Newswire (US)Volition Presents Three Cancer Detection Abstracts at ESMO 2023AMEX:VNRXVolitionRX Limited
13/10/202307:00PR Newswire (US)Volition Publishes Key Opinion Leader Roundtable Report on NETs in SepsisAMEX:VNRXVolitionRX Limited
02/10/202307:00PR Newswire (US)Volition to Reveal New Cancer Detection Method Insights at Upcoming WebinarAMEX:VNRXVolitionRX Limited
13/09/202307:00PR Newswire (US)Volition Hosts Key Opinion Leader Roundtable on Sepsis ManagementAMEX:VNRXVolitionRX Limited
14/08/202315:10PR Newswire (US)VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business UpdateAMEX:VNRXVolitionRX Limited
09/08/202307:00PR Newswire (US)VolitionRx Limited Schedules Second Quarter 2023 Earnings Conference Call and Business UpdateAMEX:VNRXVolitionRX Limited
14/07/202315:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:VNRXVolitionRX Limited
 Showing the most relevant articles for your search:AMEX:VNRX

Su Consulta Reciente

Delayed Upgrade Clock